NZX-listed AFT Pharmaceuticals is raising $10 million through a discounted share placement.

At the same time, long-time shareholder Capital Royal Group is selling all of its 16 per cent stake, worth around $58m, while the

Advertisement
Advertisement

Dividend on the way